en

PRODUCT DETAIL

Conexxence 60 mg injekčný roztok v naplnenej injekčnej striekačke

Code 0782F
MA number EU/1/25/1954/001
Product Form: sol iru 1x1 ml/60 mg (striek.inj.napl.skl.+chránič ihly)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Fresenius Kabi Deutschland GmbH, Germany
Therapeutic Class: 87 - VARIA I
ATC:
M MUSCULO-SKELETAL SYSTEM
M05 DRUGS FOR TREATMENT OF BONE DISEASES
M05B DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
M05BX Other drugs affecting bone structure and mineralization
M05BX04 Denosumab
Shelf life: 36
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(4) similar biological application
MA issued: 18.07.2025
Validity: 18.07.2030
SmPC + PL: European Medicines Agency's database
Dokument: Denosumab 60 mg_Karta pacienta.pdf  
Dokument: Denosumab 60 mg_Zoznam držiteľov.pdf  
Safety feature Yes
Data update: 04.08.2025
eu-flag.png sk-flag.png